☆ 4.2 Review

Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2020)

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Volume 34, Issue 5, Pages 903-921

Publisher

W B SAUNDERS CO-ELSEVIER INC

DOI: 10.1016/j.hoc.2020.06.007

Keywords

Therapy; BTKi; Acalabrutinib; Ibrutinib; Zanubrutinib; Tirabrutinib; Orelabrutinib

Categories

Oncology Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.